- Home
- DDI vs PACB Comparison
DDI vs PACB Comparison
Compare DDI & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDI
- PACB
- Stock Information
- Founded
- DDI 2008
- PACB 2000
- Country
- DDI South Korea
- PACB United States
- Employees
- DDI N/A
- PACB N/A
- Industry
- DDI EDP Services
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- DDI Technology
- PACB Industrials
- Exchange
- DDI Nasdaq
- PACB Nasdaq
- Market Cap
- DDI 480.7M
- PACB 462.1M
- IPO Year
- DDI 2021
- PACB 2010
- Fundamental
- Price
- DDI $9.17
- PACB $1.38
- Analyst Decision
- DDI Strong Buy
- PACB Buy
- Analyst Count
- DDI 5
- PACB 8
- Target Price
- DDI $19.60
- PACB $1.91
- AVG Volume (30 Days)
- DDI 57.4K
- PACB 8.2M
- Earning Date
- DDI 08-12-2025
- PACB 08-07-2025
- Dividend Yield
- DDI N/A
- PACB N/A
- EPS Growth
- DDI N/A
- PACB N/A
- EPS
- DDI 2.15
- PACB N/A
- Revenue
- DDI $333,256,000.00
- PACB $156,110,000.00
- Revenue This Year
- DDI $8.79
- PACB $3.36
- Revenue Next Year
- DDI $2.04
- PACB $18.20
- P/E Ratio
- DDI $4.33
- PACB N/A
- Revenue Growth
- DDI 0.24
- PACB N/A
- 52 Week Low
- DDI $8.09
- PACB $0.85
- 52 Week High
- DDI $18.21
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- DDI 39.03
- PACB 52.11
- Support Level
- DDI $9.11
- PACB $1.21
- Resistance Level
- DDI $9.70
- PACB $1.35
- Average True Range (ATR)
- DDI 0.25
- PACB 0.11
- MACD
- DDI -0.02
- PACB -0.00
- Stochastic Oscillator
- DDI 9.38
- PACB 59.37
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.